FPF
NYMX

FNY Partners Fund’s Nymox Pharmaceutical Corp NYMX Stock Holding History

FNY Partners Fund’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,000
Closed -$35K – 747
2017
Q2 		$35K Hold
8,000
– – 0.01% 302
2017
Q1 		$29K Buy
+8,000
New +$26.3K ﹤0.01% 864

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

FNY Partners Fund's NYMX Position: Q3 2017 in Review

FNY Partners Fund sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2017, closing a stake of 8,000 shares — an estimated $35K sold.

FNY Partners Fund first reported a position in NYMX in Q1 2017 and held it in 2 quarters. The position peaked at $35K in Q2 2017. 45 funds tracked by Wall St. Rank hold NYMX as of Q3 2017.

  • FNY Partners Fund reported no remaining Nymox Pharmaceutical Corp position as of Q3 2017 after selling out during the quarter.
  • FNY Partners Fund sold 8,000 Nymox Pharmaceutical Corp shares in Q3 2017, an estimated $35K.
  • FNY Partners Fund first reported a position in Nymox Pharmaceutical Corp in Q1 2017 and held it in 2 quarters.
  • FNY Partners Fund's Nymox Pharmaceutical Corp position peaked at $35K in Q2 2017.
  • 45 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2017.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.